UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
|
||
WASHINGTON,
D.C. 20549
|
||
FORM
8-K
|
||
CURRENT
REPORT
|
||
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
||
Date
of Report (date of earliest event reported)
April
25, 2007
|
||
GENESIS
MICROCHIP INC.
|
||
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
000-33477
|
77-0584301
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
No.)
|
2525
Augustine Dr.
Santa
Clara, CA 95054
|
||
(Address
of principal executive offices,
including zip code)
|
||
(408)
919-8400
|
||
(Registrant’s
telephone number, including area code)
|
||
Not
Applicable
(Former
name or former address, if changed since last
report)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
(d)
|
Exhibits.
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press
release dated April 27, 2007
|
GENESIS
MICROCHIP INC.
|
||
Date:
April 27, 2007
|
By:
|
/s/
Elias
Antoun
|
Name:
|
Elias
Antoun
|
|
Title:
|
President
& Chief Executive Officer
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press
release dated April 27, 2007
|